newborn screening programme
Congenital adrenal hyperplasia
Congenital Adrenal Hyperplasia (CAH) is the name given to a group of disorders. These cause impaired production of a chemical called cortisol.
UK NSC screening recommendation
Screening CAH is not recommended because:
- there is still some uncertainty about how common CAH is, particularly in some groups of the population
- there is not enough information to determine which groups of people should be included in any future screening programme
- currents tests are not accurate enough and may miss babies or give false positives
- studies show that screening may not be effective at reducing deaths from CAH
- screening may take place too late to benefit people with some types of CAH
Supporting documents from the 2016 review
Evidence summary Congenital adrenal hyperplasia (2016)
This document provides the evidence on which the current UK NSC recommendation is based.
UK NSC coversheet & consultation responses (2016)
This document summarises the review process including the public consultation comments.
Date previous review completed: 2016
Next review estimated to be completed: 2021 to 2022.
To see previous evidence reviews, visit the UK NSC archive.
Organisations interested in Congenital adrenal hyperplasia
These organisations have expressed interest in this recommendation and may submit responses to evidence reviews.
List of organisations
- ArchAngel MLD Trust
- British Association of Perinatal Medicine
- Clinical Genetics Society
- Faculty of Public Health
- Genetic Alliance UK
- Metabolic Support UK
- Royal College of General Practitioners
- Royal College of Midwives
- Royal College of Paediatrics and Child Health
- Royal College of Physicians
- Royal College of Physicians and Surgeons of Glasgow
- Royal College of Physicians of Edinburgh
- UK Newborn Screening Laboratories Network